CCL2 and type 2 diabetes mellitus: In this study, we determined peripheral blood mononuclear cells nuclear NF-κB p65 protein and NF-κB p65 mRNA expressions, and urinary chemokine MCP-1 and RANTES levels in patients with type 2 diabetes and matched healthy controls.